ziprasidone
- RxCUI
- 115698
- RxNorm name
- ziprasidone
- Term type
- IN
- Status
- Active
- Updated
- 2026-10-04 01:57:36
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ziprasidone | ZIPRASIDONE | REMEDYREPACK INC. | 6665279a-32ab-43ce-a258-039a6779a1a2 | 2026-08-03 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
| ziprasidone | ZIPRASIDONE | REMEDYREPACK INC. | 3834670f-cc31-4ed9-87ec-b631339ae18a | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
| ziprasidone | ZIPRASIDONE | REMEDYREPACK INC. | 48b54613-9b5f-4fcb-ba1f-22085ee0d8d1 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
| Ziprasidone | ZIPRASIDONE | Major Pharmaceuticals | ca55c149-5b9a-4144-b586-37cb5e84dc4e | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
| ziprasidone | ZIPRASIDONE | Dr. Reddy's Laboratories Limited | 396cb4a6-01a1-f73f-2a37-39df9067bf98 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
| ziprasidone | ZIPRASIDONE | NorthStar Rx LLC | 0071a228-21cc-56a6-dcc9-a7a6ceea758c | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
| Ziprasidone | ZIPRASIDONE | Chartwell RX, LLC | 7fbd9460-78a3-4160-9986-3a113de752a6 | 2023-08-07 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N05AE | Indole derivatives | ATC1-4 | ziprasidone | |
| FDASPL | N0000175430 | Atypical Antipsychotic | EPC | has_epc | ziprasidone |
| MEDRT | D010879 | Piperazines | CHEM | has_ingredient | ziprasidone hydrochloride |
| MEDRT | D010879 | Piperazines | CHEM | has_ingredient | ziprasidone |
| MEDRT | D010879 | Piperazines | CHEM | has_ingredient | ziprasidone hydrochloride, monohydrate |
| MEDRT | D013844 | Thiazoles | CHEM | has_ingredient | ziprasidone |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone hydrochloride anhydrous |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone hydrochloride, monohydrate |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone mesylate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone hydrochloride anhydrous |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone hydrochloride, monohydrate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone mesylate |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone hydrochloride, monohydrate |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone mesylate |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone hydrochloride anhydrous |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone hydrochloride, monohydrate |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone mesylate |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone hydrochloride anhydrous |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone hydrochloride, monohydrate |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone mesylate |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone hydrochloride anhydrous |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone hydrochloride |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone hydrochloride |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone hydrochloride, monohydrate |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone hydrochloride anhydrous |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone mesylate |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone mesylate |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone mesylate |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone mesylate |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone mesylate |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone mesylate |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone mesylate |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone mesylate |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone hydrochloride, monohydrate |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone hydrochloride anhydrous |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone mesylate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | ATC | N05AE04 |
| CODES | DRUGBANK | DB00246 |
| CODES | SNOMEDCT | 373389002 |
| CODES | SNOMEDCT | 409356003 |
| CODES | VUID | 4021249 |
| SOURCES | Source | Anatomical Therapeutic Chemical |
| SOURCES | Source | Drug Bank |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |